Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.
(2015) In JAMA: The Journal of the American Medical Association 313(24). p.2449-2455- Abstract
- The target for the oral erectile dysfunction drugs, phosphodiesterase type 5 (PDE5) inhibitors, is part of a pathway implicated in the development of malignant melanoma. An increased risk of melanoma in sildenafil users was recently reported.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/7478175
- author
- Loeb, Stacy ; Folkvaljon, Yasin ; Lambe, Mats ; Robinson, David ; Garmo, Hans ; Ingvar, Christian LU and Stattin, Pär
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- JAMA: The Journal of the American Medical Association
- volume
- 313
- issue
- 24
- pages
- 2449 - 2455
- publisher
- American Medical Association
- external identifiers
-
- pmid:26103029
- wos:000356663600014
- scopus:84937605684
- pmid:26103029
- ISSN
- 1538-3598
- DOI
- 10.1001/jama.2015.6604
- language
- English
- LU publication?
- yes
- id
- 9d2e9655-b502-4b6f-86fc-c596fc48e87e (old id 7478175)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26103029?dopt=Abstract
- date added to LUP
- 2016-04-01 09:52:24
- date last changed
- 2022-04-27 08:18:44
@article{9d2e9655-b502-4b6f-86fc-c596fc48e87e, abstract = {{The target for the oral erectile dysfunction drugs, phosphodiesterase type 5 (PDE5) inhibitors, is part of a pathway implicated in the development of malignant melanoma. An increased risk of melanoma in sildenafil users was recently reported.}}, author = {{Loeb, Stacy and Folkvaljon, Yasin and Lambe, Mats and Robinson, David and Garmo, Hans and Ingvar, Christian and Stattin, Pär}}, issn = {{1538-3598}}, language = {{eng}}, number = {{24}}, pages = {{2449--2455}}, publisher = {{American Medical Association}}, series = {{JAMA: The Journal of the American Medical Association}}, title = {{Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.}}, url = {{http://dx.doi.org/10.1001/jama.2015.6604}}, doi = {{10.1001/jama.2015.6604}}, volume = {{313}}, year = {{2015}}, }